Self Assembly of Short Aromatic Peptides into Amyloid Fibrils and Related Nanostructures

References

• Rochet JC, Lansbury PT Jr. Amyloid fibrillogenesis: Themes and variations. Curr Opin Struct Biol 2000; 10:60 - 68
   PubMed Web of Science ®Google Scholar
• Makin OS, Serpell LC. Structures for amyloid fibrils. FEBS J 2005; 272:5950 - 5961
   PubMed Web of Science ®Google Scholar
• Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 2006; 75:333 - 366
   PubMed Web of Science ®Google Scholar
• Jarrett JT, Lansbury PT Jr. Seeding ”one-dimensional crystallization“ of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?. Cell 1993; 73:1055 - 1058
   PubMed Web of Science ®Google Scholar
• Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002; 416:535 - 539
   PubMed Web of Science ®Google Scholar
• Klein WL. Aβ toxicity in Alzheimer's disease: Globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem Int 2002; 41:345 - 352
   PubMed Web of Science ®Google Scholar
• Sharon R, Bar-Joseph I, Frosch MP, Walsh DM, Hamilton JA, Selkoe DJ. The formation of highly soluble oligomers of α-synuclein is regulated by fatty acids and enhanced in Parkinson's disease. Neuron 2003; 37:583 - 595
   PubMed Web of Science ®Google Scholar
• Caughey B, Lansbury PT. Protofibrils pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 2003; 26:267 - 298
   PubMed Web of Science ®Google Scholar
• Porat Y, Kolusheva S, Jelinek R, Gazit E. The human islet amyloid polypeptide forms transient membrane-active pre-fibrillar assemblies. Biochemistry 2003; 42:10971 - 10977
   PubMed Web of Science ®Google Scholar
• Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003; 300:486 - 489
   PubMed Web of Science ®Google Scholar
• Glabe CG, Kayed R. Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology 2006; 66:S74 - S78
   PubMed Web of Science ®Google Scholar
• Malmo C, Vilasi S, Iannuzzi C, Tacchi S, Cametti C, Irace G, Sirangelo I. Tetracycline inhibits W7FW14F apomyoglobin fibril extension and keeps the amyloid protein in a prefibrillar, highly cytotoxic state. FASEB J 2006; 20:346 - 347
   PubMed Web of Science ®Google Scholar
• Bucciantini M, Calloni G, Chiti F, Formigli L, Nosi D, Dobson CM, Stefani M. Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem 2004; 279:31374 - 31382
   PubMed Web of Science ®Google Scholar
• Baglioni S, Casamenti F, Bucciantini M, Luheshi LM, Taddei N, Chiti F, Dobson CM, Stefani M. Prefibrillar amyloid aggregates could be generic toxins in higher organisms. J Neurosci 2006; 26:8160 - 8167
   PubMed Web of Science ®Google Scholar
• Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid b-peptide. Nat Rev Mol Cell Biol 2007; 8:101 - 112
   PubMed Web of Science ®Google Scholar
• Necula M, Kayed R, Milton S, Glabe CG. Small-molecule inhibitors of aggregation indicate that amyloid β oligomerization and fibrillization pathways are independent and distinct. J Biol Chem 2007; In press.
   Web of Science ®Google Scholar
• Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH. A specific amyloid-β protein assembly in the brain impairs memory. Nature 2006; 440:352 - 357
   PubMed Web of Science ®Google Scholar
• Barghorn S, Nimmrich V, Striebinger A, Krantz C, Keller P, Janson B, Bahr M, Schmidt M, Bitner RS, Harlan J, Barlow E, Ebert U, Hillen H. Globular amyloid β-peptide oligomer—A homogenous and stable neuropathological protein in Alzheimer's disease. J Neurochem 2005; 95:834 - 847
   PubMed Web of Science ®Google Scholar
• Tenidis K, Waldner M, Bernhagen J, Fischle W, Bergmann M, Weber M, Merkle ML, Voelter W, Brunner H, Kapurniotu A. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. J Mol Biol 2000; 295:1055 - 1071
   PubMed Web of Science ®Google Scholar
• Balbach JJ, Ishii Y, Antzutkin ON, Leapman RD, Rizzo NW, Dyda F, Reed J, Tycko R. Amyloid fibril formation by Aβ 16–22, a seven-residue fragment of the Alzheimer's β-amyloid peptide, and structural characterization by solid state NMR. Biochemistry 2000; 39:13748 - 13759
   PubMed Web of Science ®Google Scholar
• Mazor Y, Gilead S, Benhar I, Gazit E. Identification and characterization of a novel molecular- recognition and self-assembly domain within the islet amyloid polypeptide. J Mol Biol 2002; 322:1013 - 1024
   PubMed Web of Science ®Google Scholar
• Reches M, Porat Y, Gazit E. Amyloid fibril formation by pentapeptide and tetrapeptide fragments of human calcitonin. J Biol Chem 2002; 277:35475 - 35480
   PubMed Web of Science ®Google Scholar
• Reches M, Gazit E. Amyloidogenic hexapeptide fragment of medin: Homology to functional islet amyloid polypeptide fragments. Amyloid 2004; 11:81 - 89
   PubMed Web of Science ®Google Scholar
• Azriel R, Gazit E. Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide: An experimental support for the key role of the phenylalanine residue in amyloid formation. J Biol Chem 2001; 276:34156 - 34161
   PubMed Web of Science ®Google Scholar
• Porat Y, Mazor Y, Efrat S, Gazit E. Inhibition of islet amyloid polypeptide fibril formation: A potential role for heteroaromatic interactions. Biochemistry 2004; 43:14454 - 14462
   PubMed Web of Science ®Google Scholar
• Porat Y, Stepensky A, Ding FX, Naider F, Gazit E. Completely different amyloidogenic potential of nearly identical peptide fragments. Biopolymers 2003; 69:161 - 164
   PubMed Web of Science ®Google Scholar
• Pawar AP, Dubay KF, Zurdo J, Chiti F, Vendruscolo M, Dobson CM. Prediction of ”aggregation-prone“ and ”aggregation-susceptible“ regions in proteins associated with neurodegenerative diseases. J Mol Biol 2005; 350:379 - 392
   PubMed Web of Science ®Google Scholar
• Gazit E. A possible role for π-stacking in the self-assembly of amyloid fibrils. FASEB J 2002; 16:77 - 83
   PubMed Web of Science ®Google Scholar
• Naito A, Kamihira M, Inoue R, Saito H. Structural diversity of amyloid fibril formed in human calcitonin as revealed by site-directed 13C solid-state NMR spectroscopy. Magn Reson Chem 2004; 42:247 - 257
   PubMed Web of Science ®Google Scholar
• Makin OS, Atkins E, Sikorski P, Johansson J, Serpell LC. Molecular basis for amyloid fibril formation and stability. Proc Natl Acad Sci USA 2005; 102:315 - 320
   PubMed Web of Science ®Google Scholar
• Inouye H, Sharma D, Goux WJ, Kirschner DA. Structure of core domain of fibril-forming PHF/Tau fragments. Biophys J 2006; 90:1774 - 1789
   PubMed Web of Science ®Google Scholar
• Colombo G, Daidone I, Gazit E, Amadei A, Di Nola A. Molecular dynamics simulation of the aggregation of the core-recognition motif of the islet amyloid polypeptide in explicit water. Proteins 2005; 59:519 - 527
   PubMed Web of Science ®Google Scholar
• Jack E, Newsome M, Stockley PG, Radford SE, Middleton DA. The organization of aromatic side groups in an amyloid fibril probed by solid-state 2H and 19F NMR spectroscopy. J Am Chem Soc 2006; 128:8098 - 8099
   PubMed Web of Science ®Google Scholar
• Tartaglia GG, Cavalli A, Pellarin R, Caflisch A. The role of aromaticity, exposed surface, and dipole moment in determining protein aggregation rates. Protein Sci 2004; 13:1939 - 1941
   PubMed Web of Science ®Google Scholar
• Haspel N, Zanuy D, Ma B, Wolfson H, Nussinov R. A comparative study of amyloid fibril formation by residues 15–19 of the human calcitonin hormone: A single β-sheet model with a small hydrophobic core. J Mol Biol 2005; 345:1213 - 1227
   PubMed Web of Science ®Google Scholar
• Wu C, Lei H, Duan Y. The role of Phe in the formation of well-ordered oligomers of amyloidogenic hexapeptide (NFGAIL) observed in molecular dynamics simulations with explicit solvent. Biophys J 2005; 88:2897 - 2906
   PubMed Web of Science ®Google Scholar
• Caflisch A. Computational models for the prediction of polypeptide aggregation propensity. Curr Opin Chem Biol 2006; 10:437 - 444
   Google Scholar
• Bemporad F, Taddei N, Stefani M, Chiti F. Assessing the role of aromatic residues in the amyloid aggregation of human muscle acylphosphatase. Protein Sci 2006; 15:862 - 870
   PubMed Web of Science ®Google Scholar
• Reches M, Gazit E. Casting metal nanowires within discrete self-assembled peptide nano-tubes. Science 2003; 300:625 - 627
   PubMed Web of Science ®Google Scholar
• Reches M, Gazit E. Formation of closed-cage nanostructures by self-assembly of aromatic dipeptides. Nano Lett 2004; 4:581 - 585
   Web of Science ®Google Scholar
• Reches M, Gazit E. Self-assembly of peptide nanotubes and amyloid-like structures by charged-termini capped diphenylalanine peptide analogues. Israel J Chem 2005; 45:363 - 371
   Web of Science ®Google Scholar
• Reches M, Gazit E. Designed aromatic homo-dipeptides: Formation of ordered nanostructures and potential nanotechnological applications. Phys Biol 2006; 3:S10 - S19
   PubMed Web of Science ®Google Scholar
• Mahler A, Reches M, Rechter M, Cohen S, Gazit E. Rigid, self-assembled hydrogel composed of a modified aromatic dipeptide. Adv Mater 2006; 18:1365 - 1370
   Web of Science ®Google Scholar
• Yemini M, Reches M, Rishpon J, Gazit E. Novel electrochemical biosensing platform using self-assembled peptide nanotubes. Nano Lett 2005; 5:183 - 186
   PubMed Web of Science ®Google Scholar
• Reches M, Gazit E. Controlled patterning of aligned self-assembled peptide nanotubes. Nat Nanotech 2006; 1:195 - 200
   PubMed Web of Science ®Google Scholar
• Cohen T, Frydman-Marom A, Rechter M, Gazit E. Inhibition of amyloid fibril formation and cytotoxicity by hydroxyindole derivatives. Biochemistry 2006; 45:4727 - 4735
   PubMed Web of Science ®Google Scholar
• Porat Y, Abramowitz A, Gazit E. Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des 2006; 67:27 - 37
   PubMed Web of Science ®Google Scholar
• Gilead S, Gazit E. Inhibition of amyloid fibril formation by peptide analogues modified with a-aminoisobutyric acid. Angew Chem Int Ed Engl 2004; 43:4041 - 4044
   PubMed Web of Science ®Google Scholar